UNICYCIVE THERAPEUTICS, INC. Discontinued Operation, Amounts of Material Contingent Liabilities Remaining
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Discontinued Operation, Amounts of Material Contingent Liabilities Remaining of $100.00 thousand as of 2023-03-31, per its 10-Q filed 2023-08-14.
Discontinued › Notes
us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining · last filed 2024-03-28
- 2023-03-31: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $100.00K.
- 2022-09-30: Discontinued Operation, Amounts of Material Contingent Liabilities Remaining $100.00K.
| Period end | Discontinued Operation, Amounts of Material Contingent Liabilities Remaining |
|---|---|
| 2023-03-31 | $100.00K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $100.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |